The horror has finally arrived for the Mayfair elite. With patents expiring, generic weight-loss drugs are flooding the market for fifteen dollars a month. Suddenly, everyone can be thin.

Exclusivity was the whole point of the Wegovy trend. If the middle class can afford the same waistline, what is the point of being wealthy?

To save the elite, Novo Nordisk is fast-tracking a premium "High Dose" version. It is the only way to ensure the truly rich stay leaner than the crowd.

Status is now a biological race. The Global South is being flooded with cheap clones, but the boutiques of Manhattan will only stock the premium brand.

Being thin used to be a sign of discipline. Then it was a sign of money. Now, it is just a sign that you have fifteen dollars. The truly fashionable are already looking for the next impossible pill.